Vantro
Health
Market Brief
Platform
Market Brief
Compare Markets
Top 5 Markets
Global Value Dossier
Pricing & Evidence Simulator
Scenario Planner
Regulatory Tracker
Vantro Match
Insights
Match
Enterprise
Pricing
Book a call
Get Started
Market Brief
Platform
▾
Market Brief
Compare Markets
Top 5 Markets
Global Value Dossier
Pricing & Evidence Simulator
Scenario Planner
Regulatory Tracker
Vantro Match
Insights
Match
Enterprise
Pricing
Book a call
Get Started
Insights
What we learn from the markets we analyse
Market readiness rankings, analysis, and autopsies, written for the teams making the call.
All
Every piece, newest first within each section.
The Index: quarterly market readiness rankings
The Index
Quarterly rankings of markets by entry readiness. Cited, and revised each quarter.
Market Watch: short regulatory and pricing signals
Market Watch
Short signals on regulatory, pricing and procurement shifts, and what they change.
Analysis: long-form pieces on market entry
Analysis
Long-form pieces on how market entry decisions are changing, and what that means for sequencing.
Autopsies: teardowns of entry decisions that went wrong
Autopsies
Anonymised teardowns of entry decisions that went wrong, and the pattern behind each.
Product
Medical Devices
Pharmaceuticals
Biotech
Digital Health
Dimension
Regulations
Timeline
Procurement
Pricing & Reimbursement
Local Partner
Tax & Customs
Region
Sub-Saharan Africa
MENA
South Asia
Southeast Asia
East Asia
Europe
Latin America
North America
Oceania
Global
The Index
The 5 most entry-ready markets for medical devices right now
Regulatory reliance is reshaping where companies launch, and in what order.
12 August 2026
Market Watch
Market Watch: the UK reliance pathway excludes the EU
A new GB route recognises US, Canadian and Australian approvals. Not European ones.
26 July 2026
Analysis
Your first launch price is an input to every price that follows
External reference pricing is a sequencing constraint, not a fact of life.
11 August 2026
When every market prices the US: the new logic of launch sequencing
Reference pricing has turned the order of entry into a pricing decision.
25 July 2026
Regulatory reliance is a strategy, not a shortcut
The approval you already hold determines which markets open next.
23 July 2026
Autopsies
Market entry autopsy: the reference-pricing withdrawal
A therapy withdrawn from a market that had done nothing wrong.
24 July 2026